InjuryBoard New York City Archives

• Off Label Prescribing

  Jeremy Thurman | May 22, 2006 10:40 AM | 0 Comments
  Category: FDA & Prescription Drugs

  Now this has to scare you a little. "Approximately one out of every five medications prescribed by US physicians are for conditions that the drugs have not been approved for by the FDA, new study results suggest. Moreover, three quarters of these off-label uses are not backed by strong scientific evidence for safety and efficacy, the authors report." Dr. Randall S. Stafford, at the Stanford...

• Insurance company cancels policies

  Jeremy Thurman | May 18, 2006 11:46 AM | 1 Comments
  Category: Medical Malpractice

  More details have emerged about allegations that WellPoint subsidiary Blue Cross of California has routinely canceled the policies of members with health problems. The Los Angeles Times talks with attorney William Shernoff, who began gathering evidence for a class action suit last year after learning of the existence of a unit within the company responsible for looking for cases of possible...

• Clinical Trials Influenced by Drug Companies

  Jeremy Thurman | May 17, 2006 10:31 AM | 1 Comments
  Category: Miscellaneous

  Yahoo News features an article discussing a study that will be in the May 17 issue of the Journal of the American Medical Association. It brings to light information that plaintiff attorneys have been saying for years about so called unbiased studies by the drug companies. This article is referencing a Harvard study about the bias of for-profit funding in medical research.Among its findings,...

• Merck Vioxx Website

  Jeremy Thurman | May 16, 2006 10:42 AM | 0 Comments
  Category: FDA & Prescription Drugs

  http://vioxx.trickydns.com/index.asp --- This is an interesting approach taken by Merck in the continuing VIoxx saga. Merck has decided to launch a website to defend themselves publicly. Is it a stunt? You have to wonder if the litigation is starting to take a toll on Merck and more imporantly their finances. Merck can say what they want on a website but the facts have said otherwise.

• Bausch & Lomb

  Jeremy Thurman | May 15, 2006 11:14 PM | 0 Comments
  Category: FDA & Prescription Drugs

  fungal eye infection Fusarium Keratitis are being reported around the world and Bausch & Lomb announced today that it would withdraw the Moisture Loc Renu product worldwide and acknowledged that a "large number of factors" have combined to put users of Bausch & Lomb's ReNu Moisture Loc at increased risk of developing the rare but potentially dangerous fungal infection of Fusarium Keratitis. ...